These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2548620

  • 1. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN, Sinha AK.
    Biochim Biophys Acta; 1989 Aug 21; 984(1):113-8. PubMed ID: 2548620
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
    Beretz A, Briançon-Scheid F, Stierlé A, Corre G, Anton R, Cazenave JP.
    Biochem Pharmacol; 1986 Jan 15; 35(2):257-62. PubMed ID: 3002388
    [Abstract] [Full Text] [Related]

  • 3. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC, Guccione MA, Packham MA, Mustard JF.
    Thromb Haemost; 1982 Apr 30; 47(2):90-5. PubMed ID: 6285543
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
    Azuma H, Takashima Y, Ishikawa M, Yamakado T.
    Jpn J Pharmacol; 1984 Feb 30; 34(2):159-70. PubMed ID: 6205194
    [Abstract] [Full Text] [Related]

  • 5. Mepacrine-induced inhibition of human platelet cyclic-GMP phosphodiesterase.
    Yamakado T, Tanaka F, Hidaka H.
    Biochim Biophys Acta; 1984 Sep 07; 801(1):111-6. PubMed ID: 6147162
    [Abstract] [Full Text] [Related]

  • 6. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
    Simpson AW, Reeves ML, Rink TJ.
    Biochem Pharmacol; 1988 Jun 15; 37(12):2315-20. PubMed ID: 2455518
    [Abstract] [Full Text] [Related]

  • 7. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
    Macfarlane DE, Srivastava PC, Mills DC.
    J Clin Invest; 1983 Mar 15; 71(3):420-8. PubMed ID: 6298277
    [Abstract] [Full Text] [Related]

  • 8. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
    Barber AJ.
    Biochim Biophys Acta; 1976 Sep 24; 444(2):579-95. PubMed ID: 9149
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ, Davidson MM, Desjardins JV.
    Biochem J; 1978 Oct 15; 176(1):83-95. PubMed ID: 215136
    [Abstract] [Full Text] [Related]

  • 10. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R, Tschopp TB, Mittelholzer E, Baumgartner HR.
    J Pharmacol Exp Ther; 1985 Oct 15; 235(1):212-9. PubMed ID: 2995647
    [Abstract] [Full Text] [Related]

  • 11. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E.
    Br J Pharmacol; 1991 Jan 15; 102(1):251-9. PubMed ID: 1710526
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of human platelet aggregation by dihydropyrano- and dihydrofuranocoumarins, a new class of cAMP-phosphodiesterase inhibitors.
    Thastrup O, Knudsen JB, Lemmich J, Winther K.
    Biochem Pharmacol; 1985 Jun 15; 34(12):2137-40. PubMed ID: 2988567
    [Abstract] [Full Text] [Related]

  • 13. Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor Sepharose chromatography.
    Umekawa H, Tanaka T, Kimura Y, Hidaka H.
    Biochem Pharmacol; 1984 Nov 01; 33(21):3339-44. PubMed ID: 6093810
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA, Reimann S, Schrör K.
    Br J Pharmacol; 1999 Jan 01; 126(2):415-20. PubMed ID: 10077233
    [Abstract] [Full Text] [Related]

  • 16. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
    Hall DA, Hourani SM.
    Biochem Pharmacol; 1994 Mar 15; 47(6):1013-8. PubMed ID: 8147900
    [Abstract] [Full Text] [Related]

  • 17. HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro.
    Ruppert D, Weithmann KU.
    Life Sci; 1982 Nov 08; 31(19):2037-43. PubMed ID: 6294426
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
    Dawicki DD, Agarwal KC, Parks RE.
    Thromb Res; 1986 Jul 15; 43(2):161-75. PubMed ID: 3016942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.